Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia
CHICAGO, July 31 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced that it received a complete response letter
today from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Restanza(TM) (cethrom...
CEL-SCI Corporation Releases Letter to Shareholders
VIENNA, Va., July 7 /PRNewswire-FirstCall/ -- The following letter
is being released by CEL-SCI Corporation (NYSE Amex: CVM ) to its shareholders:
Dear Fellow Shareholders:
Recently we have been hearing a great deal about the pandemic caused by the H1N1 swine flu. You may think to...
New Generation Biofuels Signs Letter of Intent with Instituto Costarricense de Electricidad (ICE) of Costa Rica
LAKE MARY, Fla., June 22 /PRNewswire-FirstCall/ -- Renewable fuels provider New Generation Biofuels Holdings, Inc. (Nasdaq: NGBF ) today announced that it has signed a Letter
of Intent with Instituto Costarricense de Electricidad (ICE), an Autonomous Institution of the Government of...
ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema
- Company Also Granted Expansion of Prophylaxis Therapy Label to Include Patient Labeling for Self-Administration -
EXTON, Pa., June 4 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that it has received a Complete Response letter
from the U.S. Food and Dr...
Mach One CEO Letter to Shareholders
BELGIUM, Wis., April 15 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces Monte B. Tobin, the President and CEO, has released the following letter
to Mach One's shareholders:
Dear Fellow Shareholders:
NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business
PETACH TIKVA, Israel, April 1 /PRNewswire-FirstCall/ -- NexGen Biofuels
Ltd. (OTCBB: NXGNF.OB), today announced that it has signed a non-binding
Letter of Intent with World Venture Management Inc., a Nevada based company
(herein referred to as ("WVM" ) and Mac Bioventures, Inc. The transaction...
Isolagen, Inc. Receives Notification Letter from Amex
EXTON, Pa., March 20 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex: ILE ) today announced that on March 17, 2009, it received notice from the Amex (the "Exchange") notifying the Company it is not in compliance with Section 1003(a)(iv) of the Exchange's Company Guide (the "Company Guide"). S...
JAG Media Holdings, Inc. Announces Letter of Intent for the Acquisition of CardioGenics Inc. by a Wholly-Owned Subsidiary of JAG Media
BOCA RATON, Fla., March 13 /PRNewswire-FirstCall/ -- JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) announced today that it has entered into a letter
of intent with CardioGenics Inc. and its principal stockholder, pursuant to which CardioGenics will be acquired by JAG Media through its subsid...
Cytopia Letter to Progen Shareholders
MELBOURNE, Australia, Feb. 25 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has today circulated a letter
and other materials to Progen Pharmaceuticals Limited (ASX: PGL) shareholders. The letter
provides an update on the current shareholders requisitioned meeting scheduled for 27 March 2009 and prov...
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional information regarding the company's supplemental New Drug Application (sNDA)...
FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
BOTHELL, Wash., Jan. 20 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD ) today announced that the U. S. Food and Drug Administration (FDA) has issued a Complete Response letter
for its Abbreviated New Drug Application (ANDA) for pseudoephedrine. The application, filed by SCOLR on Augus...
FDA Issues Complete Response Letter for Iclaprim
REINACH Switzerland, January 19 /PRNewswire-FirstCall/ -- Arpida Ltd.
(SWX: ARPN) announces today that it has received a Complete Response Letter
from the U.S. Food and Drug Administration (FDA) regarding its New Drug
Application (NDA) for intravenous iclaprim for the treatment of complicated
Mach One Corporation Enters Letter of Intent
BELGIUM, Wis., Jan. 5 /PRNewswire-FirstCall/ -- Mach One Corporation
(Pink Sheets: MNCN), a biological solutions company that develops products
that produce a positive long term benefit to the agricultural and consumer
market, announced today that it has entered into a non-binding letter
Palatin Technologies Receives Notification Letter from NYSE Alternext US
Company Expects Its Common Stock to Remain Listed While it
Engages in Compliance Process
CRANBURY, N.J., Dec. 30 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Alternext US: PTN) today reported it received notice from NYSE Alternext US LLC (the "Exchange", formerly known as the...
CEL-SCI Corporation Releases Letter to Shareholders
VIENNA, Va., Dec. 12 /PRNewswire-FirstCall/ -- The following letter
is being released by CEL-SCI CORPORATION (NYSE Alternext US: CVM) to its shareholders:
Dear Fellow Shareholders:
Recently we have had two pieces of important news for CEL-SCI Corporation and its shareholders. ...
Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
Urges Board to Take Immediate Action to Protect and Maximize Shareholder Value
CHICAGO, Dec. 11 /PRNewswire/ -- Biotechnology Value Fund, L.P., the owner, together with its affiliates, of nearly 29% of the outstanding shares of common stock of Avigen, Inc. (Nasdaq: AVGN ) announced toda...
Eklin Signs Letter of Intent With ZONARE for Distribution of Zone Sonography(TM) z.one System
SANTA CLARA, Calif., Dec. 10 /PRNewswire/ -- Eklin Medical Systems, Inc.
today announced it has signed a letter
of intent with ZONARE Medical Systems,
Inc., a developer of premium ultrasound systems, for the distribution of
ZONARE's z.one ultrasound system to the equine veterinary care market in N...
Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics
OMAHA, Neb. and HOUSTON, Dec. 2 /PRNewswire-FirstCall/ -- Transgenomic,
Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC
Bulletin Board: PWRM) today announced that Transgenomic has signed a letter
intent to acquire exclusive rights for Power3 Medical's Neurodegenerative
Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
WAYNE, Pa., Nov. 28 /PRNewswire-FirstCall/ -- Encorium Group, Inc.
(Nasdaq: ENCO ), a full service multinational clinical research organization
(CRO) conducting studies in over 30 countries for many of the world's leading
pharmaceutical and biotechnology companies, today announced that on Novemb...
Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
NEW YORK, Nov. 21 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. ( OTC Bulletin Board : ILNS ), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease released today the following Letter
SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R)
BARCELONA, Spain, November 5 /PRNewswire/ -- SALVAT announced today the
submission of the response to the FDA Approvable Letter
(Ciprofloxacin 0.2% Otic Solution in Single Dose Containers). In an
received on April 6, 2006, the FDA requested additional
Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
BETHESDA, Md., Oct. 23 /PRNewswire-FirstCall/ -- Spherix Incorporated
(Nasdaq: SPEX ) reported that on October 22, 2008, it received written
notification from Nasdaq advising the Company that, because of the current
instability in the financial markets, Nasdaq has suspended enforcement of
Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
SAN DIEGO, Oct. 7 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq:
VICL) and AnGes MG, Inc., have signed a non-binding Letter
indicating their mutual interest to license the development and marketing
rights for Vical's pandemic influenza DNA vaccines in Japan to AnGes. AnGes
Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
SEATTLE, Sept. 17 /PRNewswire-FirstCall/ - On August 20, 2008
Oncothyreon Inc. (Nasdaq: ONTY ) (TSX: ONY) disclosed that it had received a
letter from The Nasdaq Stock Market indicating that (i) it did not comply
with the requirements for continued listing on The NASDAQ Global Market
Synvista Therapeutics Posts Letter to Stockholders on Web Site
MONTVALE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Synvista
Therapeutics, Inc. (Amex: SYI ) today announced that a Letter
Stockholders is now posted to the Company's Web site http://www.synvista.com . The
text is as follows:
To Our Stockholders:
The team at Synvista Therapeutics has m...
Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd.
XI'AN, China, Sept. 5 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-
Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB) (the "Company"),
a leading developer and producer of plant extracts and pharmaceutical raw
materials for use in pharmaceutical, nutraceutical and food production in
CEO's Letter to Shareholders of Imaging Diagnostic Systems, Inc.
FORT LAUDERDALE, Fla., Aug. 5 /PRNewswire-FirstCall/ -- Imaging
Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS)
Dear IDSI Shareholders,
As many of you know, I returned to the company three months ago to
assume the position of Interim CEO and Chairman of the Board; we have
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
Deal Includes POCKETECG Wireless Beat-To-Beat Heart Monitoring and Diagnostic System
SUNRISE, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Bioheart, Inc.,
(Nasdaq: BHRT ), announced it has entered into a non-binding letter
intent to acquire MEDICALGORITHMICS, Ltd. an...
Eisai Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures
FDA's Not Approvable Letter
Outlines Pathway to Potential Approval
WOODCLIFF LAKE, N.J., July 25 /PRNewswire/ -- Eisai Corporation of
North America today announced that it has received a not approvable letter
from the U.S. Food and Drug Administration (FDA), which outlines a pathway
Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
- Company Will Request Hearing to Present Plans for Regaining Compliance - - NASDAQ Hearing Panel Has Discretion to Grant Peregrine Up to an Additional 180 Days to Regain Compliance -
- Peregrine Currently Meets All Other NASDAQ Capital Market Initial Listing Requirements Ot...
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Company Announces Revised Operating Plan to Respond to NEBIDO Delay
LEXINGTON, Mass., June 30 /PRNewswire-FirstCall/ -- Indevus
Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced that it has received
an approvable letter
from the U.S. Food and Drug Administration (FDA) for
Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary
MUMBAI, India, June 24 /PRNewswire-FirstCall/ -- Sun Pharmaceutical
Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:
524715) yesterday sent a letter
to Dr. Barrie Levitt, Chairman of the Board
of Directors of Taro Pharmaceutical Industries Ltd. (Taro, Pink Sheets:
Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine
POWAY, Calif., May 22 /PRNewswire-FirstCall/ -- Digirad Corporation
(Nasdaq: DRAD ), a leading provider of medical diagnostic imaging systems
and services to physicians' offices, hospitals and imaging centers, today
announced the signing of a letter
of understanding with Johns Hopkins
ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
Microbix to Acquire Commercialized Thrombolytic and Related Assets for $17 Million
TUCSON, Ariz., May 7 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc.
(Nasdaq: IMRX ) today announced that it has signed a letter
of intent in
which Microbix Biosystems will acqu...
Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
KENILWORTH and WHITEHOUSE STATION, N.J., April 25 /PRNewswire/ --
Schering-Plough/MERCK Pharmaceuticals (SPM) today confirmed that it
received a not-approvable letter
from the U.S. Food and Drug Administration
(FDA) for a proposed fixed combination of loratadine and montelukast for
CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
Reverse Stock Split Proposal to Remedy
SAN DIEGO, April 18 /PRNewswire-FirstCall/ -- CardioDynamics
International Corporation (Nasdaq: CDIC ), the innovator and leader of
impedance cardiography (ICG) technology, today announced that, as
anticipated, it received a Nasdaq Staff...
Cell Therapeutics, Inc. Announces Receipt of Letter From the NASDAQ Stock Market Regarding Non-Compliance With the Minimum Bid Price Requirement
SEATTLE, April 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq and MTAX: CTIC) today announced that on April 16, 2008 it
received a letter
from The NASDAQ Stock Market indicating that for the last
30 consecutive business days the bid price of its common stock has closed
U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
DALLAS and REYKJAVIK, Iceland, April 3, 2008 /PRNewswire/ -- U.S.
Preventive Medicine(R), ( http://www.USPreventiveMedicine.com ) the leader in
prevention, and deCODE Genetics, the global leader in gene discovery, today
announced they have signed a letter
of intent to add genetic testing to
Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
BOTHELL, Wash., April 1, 2008 /PRNewswire-FirstCall/ -- Cardiac Science
(Nasdaq: CSCX ), a global leader in advanced cardiac diagnosis,
resuscitation, rehabilitation, and informatics products, announced today
that it signed a letter
of intent to begin establishing Heartcentrix(R) ECG
Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
- Company Plans to Request Timely Hearing before a NASDAQ Listing Qualifications Panel -
FREMONT, Calif., March 28 /PRNewswire-FirstCall/ -- Vermillion, Inc.
(Nasdaq: VRML , VRMLD) (the "Company"), a molecular diagnostics company,
announced today that on March 18, 2...